Interleukin-10: a cytokine used by tumors to escape immunosurveillance

被引:91
作者
Salazar-Onfray, F
机构
[1] Univ Chile, Fac Med, Inst Biomed Sci, Program Immunol, Santiago 7, Chile
[2] Karolinska Hosp, Radiumhemmet, Dept Pathol & Oncol, S-10401 Stockholm, Sweden
关键词
D O I
10.1007/BF02785841
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mechanisms whereby malignant cells can elude the recognition of the immune system, by what is termed 'immunological escape', have attracted major attention of tumor immunologists during the past decade. In this review, the role of the immunosuppuessive cytokine interleukin-10 (IL-10) will be discussed as a strategy used by tumors to avoid recognition by cytotoxic T lymphocytes (CTL).
引用
收藏
页码:86 / 94
页数:9
相关论文
共 99 条
[1]   ADOPTIVE IMMUNOTHERAPY OF ADVANCED MELANOMA PATIENTS WITH INTERLEUKIN-2 (IL-2) AND TUMOR-INFILTRATING LYMPHOCYTES SELECTED INVITRO WITH LOW-DOSES OF IL-2 [J].
ARIENTI, F ;
BELLI, F ;
RIVOLTINI, L ;
GAMBACORTIPASSERINI, C ;
FURLAN, L ;
MASCHERONI, L ;
PRADA, A ;
RIZZI, M ;
MARCHESI, E ;
VAGLINI, M ;
PARMIANI, G ;
CASCINELLI, N .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (05) :315-322
[2]   ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].
ARTEAGA, CL ;
HURD, SD ;
WINNIER, AR ;
JOHNSON, MD ;
FENDLY, BM ;
FORBES, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576
[3]   PROSTAGLANDIN E(2) DOWN-REGULATES THE EXPRESSION OF HLA-DR ANTIGEN IN HUMAN COLON ADENOCARCINOMA CELL-LINES [J].
ARVIND, P ;
PAPAVASSILIOU, ED ;
TSIOULIAS, GJ ;
QIAO, LA ;
LOVELACE, CIP ;
DUCEMAN, B ;
RIGAS, B .
BIOCHEMISTRY, 1995, 34 (16) :5604-5609
[4]   HAM-2 CORRECTS THE CLASS-I ANTIGEN-PROCESSING DEFECT IN RMA-S CELLS [J].
ATTAYA, M ;
JAMESON, S ;
MARTINEZ, CK ;
HERMEL, E ;
ALDRICH, C ;
FORMAN, J ;
LINDAHL, KF ;
BEVAN, MJ ;
MONACO, JJ .
NATURE, 1992, 355 (6361) :647-649
[5]   Induction of transporter associated with antigen processing by interferon γ confers endothelial cell cytoprotection against natural killer-mediated lysis [J].
Ayalon, O ;
Hughes, EA ;
Cresswell, P ;
Lee, J ;
O'Donnell, L ;
Pardi, R ;
Bender, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2435-2440
[6]   HIGH-LEVELS OF INTERLEUKIN-10 PRODUCTION IN-VIVO ARE ASSOCIATED WITH TOLERANCE IN SCID PATIENTS TRANSPLANTED WITH HLA MISMATCHED HEMATOPOIETIC STEM-CELLS [J].
BACCHETTA, R ;
BIGLER, M ;
TOURAINE, JL ;
PARKMAN, R ;
TOVO, PA ;
ABRAMS, J ;
MALEFYT, RD ;
DEVRIES, JE ;
RONCAROLO, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :493-502
[7]  
BECKER S, 1978, J NATL CANCER I, V61, P1495
[8]   HUMAN-B CELL INTERLEUKIN-10 [J].
BENJAMIN, D ;
PARK, CD ;
SHARMA, V .
LEUKEMIA & LYMPHOMA, 1994, 12 (3-4) :205-210
[9]  
BLANCKAERT VD, 1993, CANCER RES, V53, P4075
[10]   A FUNCTIONAL DICHOTOMY IN CD4+ LYMPHOCYTES-T [J].
BOTTOMLY, K .
IMMUNOLOGY TODAY, 1988, 9 (09) :268-274